tradingkey.logo

LeMaitre Vascular Inc

LMAT
View Detailed Chart

81.130USD

-0.240-0.29%
Close 06/13, 16:00ETQuotes delayed by 15 min
1.83BMarket Cap
41.62P/E TTM

LeMaitre Vascular Inc

81.130

-0.240-0.29%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.29%

5 Days

-3.57%

1 Month

-2.61%

6 Months

-19.43%

Year to Date

-11.95%

1 Year

+1.30%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 11 analysts
BUY
Current Rating
104.500
Target Price
28.81%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

93
Total
4
Median
7
Average
Company name
Ratings
Analysts
LeMaitre Vascular Inc
LMAT
11
Boston Scientific Corp
BSX
34
Intuitive Surgical Inc
ISRG
33
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
32
Veeva Systems Inc
VEEV
32
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(3)
Buy(0)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.096
Neutral
RSI(14)
44.341
Neutral
STOCH(KDJ)(9,3,3)
32.892
Sell
ATR(14)
2.047
Low Volatility
CCI(14)
-62.813
Neutral
Williams %R
68.892
Sell
TRIX(12,20)
-0.061
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
82.518
Sell
MA10
82.593
Sell
MA20
82.519
Sell
MA50
83.645
Sell
MA100
87.938
Sell
MA200
91.161
Sell

News

More news coming soon, stay tuned...

Company

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Ticker SymbolLMAT
CompanyLeMaitre Vascular Inc
CEOMr. George W. Lemaitre
Websitehttps://www.lemaitre.com/
KeyAI